AI & ML
Doubly-robust causal inference for multi-valued treatment regimes with recurrent neural networks
arXiv stat.ML0 views
arXiv:2611.08077v1 Announce Type: cross Abstract: We propose a doubly-robust method to estimate the causal effects of multi-valued treatment regimes on patient outcomes. A multi-valued treatment regime assigns personalized treatments from a set of competing options based on a patient's history. Existing methods for optimal treatment regimes are largely limited to binary or continuous treatments. We extend the longitudinal targeted minimum loss-based estimator (LTMLE) to accommodate multi-valued treatments by modeling treatment assignments with a multinomial model. We further integrate recurrent neural networks (RNNs) into the LTMLE framework as learners for the outcome, treatment, and censoring models, and compare this approach to ensemble machine learning. Simulation studies show that LTMLE with either ensemble machine learning or RNNs is approximately unbiased, with close to nominal coverage, whereas sequential g-computation with ensemble machine learning is substantially biased under a dynamic rule. A multinomial treatment model performs similarly to a series of binomial regressions with ensemble machine learning, but yields more stable inference when the treatment model is an RNN.
Source:https://arxiv.org/abs/2611.08077PreviousOptimal Learning in Games with Arbitrary Delays: Best-of-Both-Worlds for Self-Play and Adversarial OpponentsNextBUMP: Brief Unexpected Mid-Interpolation Peak
Related posts
Show HN: UUMit – turn idle machines into model endpoints
0Hacker News Show
Show HN: CLI for Cybersecurity Triage
0Hacker News Show

Save 26% on this 142-piece toolkit for your PC repairs and hobbyist projects, now under $28
0Tom's Hardware
‘Mathematics is more than a mechanical process’ — why I think the field will survive OpenAI’s disruption
0Nature News
Preprint platform offers to pay researchers to review papers, but questions remain
0Nature News

I’ve reviewed almost every Android foldable this year — here’s how the iPhone Duo compares
0The Verge